Company profile
Spliceor Unleashing Gene Therapy Through RNA Trans-splicing
Spliceor Ltd is a UK company with status active founded in 2020 based in East of England.
Financial period: 1 Sep 2023 to 31 Aug 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
CS01 | Transaction MzQzMzA3OTkwNWFkaXF6a2N4
Published 22 Aug 2024 09:39
Company registered at Companies House
1 Jun 2025 to 31 May 2027
Spliceor is an early-stage Cambridge University spin-out company from the Department of Medicine developing novel gene therapies for aggressive cancers for which current treatments are ineffective, often due to mutational evasion developing towards standard therapies. Spliceor targets molecules found exclusively in cancer cells using them to generate a le...
1 Jun 2023 to 30 Nov 2023
Spliceor Ltd is an early-stage University of Cambridge spin-out company developing novel gene therapies for certain types of aggressive cancers for which current treatments are ineffective. Spliceor targets molecules found exclusively in cancer cells using them to generate a lethal gene product within the cancer cell. The Spliceor team has identified a sp...
